ENDOCYTE INC Income Statement

Ask AI

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2017 12 months to Dec 31, 2017	FY2016 12 months to Dec 31, 2016	FY2015 12 months to Dec 31, 2015	FY2014 12 months to Dec 31, 2014	FY2013 12 months to Dec 31, 2013
Revenue:
Collaboration revenue
Total revenue
Operating expenses:
Research and development
General and administrative
Acquired in-process research and development
Total operating expenses
Loss from operations
Other income (expense), net:
Interest income
Interest expense
Interest income, net
Other income (expense), net
Net loss
Net income (loss) per share - diluted (in dollars per share)
Net loss per share -basic and diluted (in dollars per share)

Items included in other comprehensive income (loss):
Unrealized gain (loss) on foreign currency translation
Unrealized gain on foreign currency translation
Unrealized gain (loss) and amounts reclassified to net loss on available-for-sale securities
Other comprehensive income (loss)
Comprehensive loss
Weighted-average number of common shares used in net income (loss) per share calculation - diluted (in shares)
Weighted-average number of common shares used in net loss per share calculation - basic and diluted (in shares)

Comments